Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesOther Gross PP&E AdjustmentsShares Issued
Ratios

Theravance Biopharma (TBPH) Long-Term Debt Issuances (2020)

Historic Long-Term Debt Issuances for Theravance Biopharma (TBPH) over the last 1 years, with Q1 2020 value amounting to $380.0 million.

  • Theravance Biopharma's Long-Term Debt Issuances changed N/A to $380.0 million in Q1 2020 from the same period last year, while for Dec 2020 it was $380.0 million, marking a year-over-year change of. This contributed to the annual value of $380.0 million for FY2020, which is N/A changed from last year.
  • Per Theravance Biopharma's latest filing, its Long-Term Debt Issuances stood at $380.0 million for Q1 2020.
  • Over the past 5 years, Theravance Biopharma's Long-Term Debt Issuances peaked at $380.0 million during Q1 2020, and registered a low of $380.0 million during Q1 2020.